BioPharma Dive
healthCenter
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsytranslating…
At a big meeting for cardiovascular medicines, Cytokinetics and Arrowhead aimed to separate their drugs from competitors while a failed study pressured Alnylam.
Keywords#Arrowhead’s#Cytokinetics’#ESC#arrowhead#cytokinetics